article thumbnail

The digital transformation of pharma’s physician engagement strategies

pharmaphorum

In doing so it’s compounded pre-existing pressure with pharma, where schedules are shrinking and policies are often already restrictive enough to build barriers for effective physician engagement. The threat of disease spread and other risk factors from COVID-19 have only compounded this.

article thumbnail

May 2023 Newsletter

Safe Biologics

Coming Soon: ASBM/GaBI Webinar on IRA’s Medicare Price Negotiation Provisions ASBM and the Generics and Biosimilars Initiative (GaBI) are in the final planning stages for the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NABP’s Compounding Pharmacy Accreditation Shows Your Pharmacy’s Alignment to USP Standards

National Association of Boards of Pharmacy

On November 1, 2023, long-awaited revisions to the United States Pharmacopeia (USP) Chapters <795>: Pharmaceutical Compounding – Nonsterile Preparations and <797>: Pharmaceutical Compounding – Sterile Preparations became official. Chapters <795> and <797> present the standards for preparing compounded medications.

article thumbnail

Immuno-oncology market set to grow in billions, but access concerns remain

Pharmaceutical Technology

While the market was worth over $6 billion in 2012, this has now grown to nearly $48 billion only a decade later, said Avigayil Chalk, PhD, GlobalData’s Senior Oncology and Haematology analyst, at an immuno-oncology webinar held on May 23. This high compound annual growth rate of 23.6%

Immunity 105
article thumbnail

Only 2 per cent medicines undergo quality control checks: Former IMA President

Express Pharma

HEAL Health recently organised a webinar titled ‘Demystifying the NMC Guidelines Conundrum’ against the backdrop of the recent postponement of the National Medical Commission (NMC) guidelines. The insights that emerged encompassed a spectrum of perspectives, shedding light on intricate challenges and potential solutions.

article thumbnail

May 2023 Newsletter

Safe Biologics

Coming Soon: ASBM/GaBI Webinar on IRA’s Medicare Price Negotiation Provisions ASBM and the Generics and Biosimilars Initiative (GaBI) are in the final planning stages for the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA).

article thumbnail

FIP TREATMENT IN THE USA: Compounded GS-441524 tablets are now available! Learn to start treating FIP cases in your practice

epicur

Watch It Now The post FIP TREATMENT IN THE USA: Compounded GS-441524 tablets are now available! Get the most up-to-date information on treatment and monitoring protocols for FIP that are being routinely utilized in Australia, the UK and Japan – and how you can now confidently treat cases in the US!